Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN103130782A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN103130782A details a hydroxylamine-based route for Lafutidine intermediates, eliminating dihydro impurities and ensuring 99.88% purity for reliable API manufacturing.